DUBLIN, Nov. 3, 2023 /PRNewswire/ — The “Global Automated and Closed Cell Therapy Processing Systems Market 2023-2030” report has been added to ResearchAndMarkets.com’s offering.
The global automated and closed cell therapy processing systems market is poised for substantial growth, with a projected market size of USD 3.66 billion by 2030, reflecting an impressive compound annual growth rate (CAGR) of 18.2% over the forecast period. Market players are strategically investing in automation to expedite cell therapy product development, thereby fueling the market’s expansion.
{INFOGRAPHIC_PLACEHOLDER}
Market Growth Catalysts:
-
Automation Revolution: Leading market players are channeling significant investments into automating cell therapy processes, a strategic move to accelerate product development and, consequently, drive market growth.
-
GMP Manufacturing Facilities: The expansion of Good Manufacturing Practices (GMP) facilities supports the adoption of automated processes for commercial operations, further boosting the market.
-
Single-Use Disposable Tubing Sets and Bags: The wide application scope of single-use disposable tubing sets and bags facilitates the automated processing of therapy research and development, enhancing market prospects.
-
COVID-19’s Impact: The rapid growth in COVID-19 cases has amplified the focus on automation technologies. Companies are raising funds to develop advanced therapies and regenerative medicines to combat the pandemic, contributing to market growth.
Key Market Highlights:
-
Cell Expansion Workflow Dominance: The cell expansion workflow segment claimed the largest revenue share in 2022, driven by a growing emphasis on achieving high output yield.
-
Cell Separation Workflow Growth: The cell separation workflow segment is poised to register the fastest CAGR, bolstered by an increasing number of stem cell therapy research and development programs.
-
Apheresis and Cryopreservation Workflow: Automated apheresis and cryopreservation workflows are expected to witness considerable growth due to the rising focus on cell preservation and sorting for cell therapies.
-
Non-Stem Cellular Therapies Success: The non-stem cellular therapies segment led the market in 2022 and will continue to expand steadily, with the success of CAR T therapies being a significant driver.
-
Pre-Commercial/R&D Scale Dominance: The pre-commercial/R&D scale segment captured the highest revenue share in 2022, attributed to an increased number of research and innovation activities for new drug and therapy developments.
-
North America Reigns: North America emerged as the highest revenue-generating region in 2022, thanks to the presence of numerous approved therapies driving market players to invest in more research and development programs.
-
Strategic Initiatives: Companies are actively engaged in strategic initiatives such as partnerships and collaborations to secure higher market shares. An example is Fresenius Kabi’s joint venture with Bio-Techne to launch ScaleReady, a scalable and versatile therapy manufacturing platform in January 2021.
Key Attributes
|
Report Attribute |
Details |
|
No. of Pages |
136 |
|
Forecast Period |
2022-2030 |
|
Estimated Market Value (USD) in 2022 |
$944.8 Million |
|
Forecasted Market Value (USD) by 2030 |
$3.66 Billion |
|
Compound Annual Growth Rate |
18.2 % |
|
Regions Covered |
Global |
Key Topics Covered
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Automated and Closed Cell Therapy Processing Systems Market Variables, Trends & Scope
Chapter 4. Automated and Closed Cell Therapy Processing Systems Market: Workflow Estimates & Trend Analysis
Chapter 5. Automated and Closed Cell Therapy Processing Systems Market: Type Estimates & Trend Analysis
Chapter 6. Automated and Closed Cell Therapy Processing Systems Market: Scale Estimates & Trend Analysis
Chapter 7. Automated and Closed Cell Therapy Processing Systems Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
Companies Mentioned
- Miltenyi Biotec
- Lonza
- Fresenius Kabi
- Cytiva (Danaher Corporation)
- Biospherix, Ltd.
- Terumo Corporation
- Sartorius AG
- Thermogenesis Holdings, Inc.
- Cellares Inc.
- Thermo Fisher Scientific, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/o5r52m
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:SOURCE Research and Markets
Featured image: Megapixl © Boggy